Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Multi-omic landscaping of human midbrains identifies neuroinflammation as major disease mechanism in advanced-stage Parkinson’s disease

Lucas Caldi Gomes, Ana Galhoz, Gaurav Jain, Anna-Elisa Roser, Fabian Maass, Eleonora Carboni, Elisabeth Barski, Christof Lenz, Katja Lohmann, Christine Klein, Mathias Bähr, André Fischer, Michael P. Menden, Paul Lingor
doi: https://doi.org/10.1101/2021.06.08.21258527
Lucas Caldi Gomes
1Department of Neurology, Rechts der Isar Hospital, Technical University of Munich; Ismaninger Str. 22, 81675 München, Germany
2Department of Neurology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Galhoz
3Institute of Computational Biology, Helmholtz Zentrum München GmbH - German Research Center for Environmental Health, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany
4Department of Biology, Ludwig-Maximilians University Munich, Großhaderner Straße 2, 82152 Martinsried, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaurav Jain
5Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Grisebachstr. 5, 37075 Göttingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna-Elisa Roser
2Department of Neurology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabian Maass
2Department of Neurology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleonora Carboni
2Department of Neurology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Barski
2Department of Neurology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christof Lenz
6Institute of Clinical Chemistry, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany
6aBioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katja Lohmann
7Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Klein
7Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathias Bähr
2Department of Neurology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen Germany
5Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Grisebachstr. 5, 37075 Göttingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Fischer
5Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Grisebachstr. 5, 37075 Göttingen, Germany
8Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Grisebachstr. 5, 37075 Göttingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Menden
3Institute of Computational Biology, Helmholtz Zentrum München GmbH - German Research Center for Environmental Health, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany
4Department of Biology, Ludwig-Maximilians University Munich, Großhaderner Straße 2, 82152 Martinsried, Germany
9German Centre for Diabetes Research (DZD e.V.), Ingolstädter Landstraße 1, 85764 Neuherberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Lingor
1Department of Neurology, Rechts der Isar Hospital, Technical University of Munich; Ismaninger Str. 22, 81675 München, Germany
10German Center for Neurodegenerative Diseases (DZNE), Feodor-Lynen-Straße 17, 81377 München, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: paul.lingor@tum.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Parkinson’s disease (PD) is the second most common neurodegenerative disorder whose prevalence is rapidly increasing worldwide. The disease mechanisms of sporadic PD are not yet completely understood. Therefore, causative therapies are still lacking. To obtain a more integrative view of disease-mediated alterations, we investigated the molecular landscape of PD in human post-mortem midbrains. Tissue from 13 PD patients and 10 controls was subjected to small RNA sequencing, transcriptomics, and proteomics analysis. Differential expression analyses were performed reveal multiple deregulated molecular targets linked to known pathomechanisms of PD as well as novel processes. We found significant differential expression of miR-539-3p, miR-376a-5p, miR-218-5p, and miR-369-3p, the valid miRNA-mRNA interacting pairs of miR-218-5p/RAB6C, and miR-369-3p/GTF2H3, as well as multiple proteins relevant in the pathology of PD, including CHI3L1, SELENBP1, PRDX1, HSPA1B, and TH. Vertical integration of multiple omics analyses allowed to validate disease-mediated molecular alterations across different molecular layers and functional annotation of differentially expressed targets identified a strong enrichment of pathways related to inflammation and activation of the immune response. This suggests that neuroinflammation may significantly contribute to disease progression in PD and may be a promising therapeutic target in advanced stages of PD.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain, Goettingen, Germany (PL), and by Bridging Funds from the Goettingen Graduate Center for Neurosciences, Biophysics, and Molecular Biosciences (LCG).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All human midbrain samples were provided by the Parkinson's UK Brain Bank (Imperial College London, London, England). The samples were conceded to the Lingor Lab (Department of Neurology, University Medical Center Goettingen, Goettingen, Germany). Ethical approval was given by the Multicenter Research Ethics Committee (07/MRE09/72).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Competing Interest Statement: The authors declare no conflict of interest for this study.

Data Availability

RNA sequencing and proteomics datasets were deposited in public repositories (the European Genome-phenome Archive (EGA) and the Proteomics Identifications Database (PRIDE), respectively) following applicable guidelines. RNA sequencing data are stored under the accession number EGAD00001006883. Proteomics data are available via ProteomeXchange with the identifier PXD023618.

  • Figure legends – Abbreviations

    CTR
    control
    PD
    Parkinson’s disease
    PMI
    postmortem interval
    Age
    age at death
    NP diagnosis
    neuropathological diagnosis
    Gender
    F-females/M-males
    LBDBS
    Lewy body disease brainstem variant
    LBDE
    Lewy body disease early-neocortical stage
    LBDN
    Lewy body disease neocortical stage
    miRNA
    microRNA
    GO
    Gene Ontology
    BP
    biological process
    CC
    cellular compartment
    KEGG
    Kyoto Encyclopedia of Genes and Genomes
    FDR
    false discovery rate
    DE
    differentially expressed
    FC
    fold change
    piRNA
    Piwi-interacting RNA
    rRNA
    ribosomal RNA
    snoRNA
    small nucleolar RNA
    sncRNA
    small non-coding RNA
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted June 12, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Multi-omic landscaping of human midbrains identifies neuroinflammation as major disease mechanism in advanced-stage Parkinson’s disease
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Multi-omic landscaping of human midbrains identifies neuroinflammation as major disease mechanism in advanced-stage Parkinson’s disease
    Lucas Caldi Gomes, Ana Galhoz, Gaurav Jain, Anna-Elisa Roser, Fabian Maass, Eleonora Carboni, Elisabeth Barski, Christof Lenz, Katja Lohmann, Christine Klein, Mathias Bähr, André Fischer, Michael P. Menden, Paul Lingor
    medRxiv 2021.06.08.21258527; doi: https://doi.org/10.1101/2021.06.08.21258527
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Multi-omic landscaping of human midbrains identifies neuroinflammation as major disease mechanism in advanced-stage Parkinson’s disease
    Lucas Caldi Gomes, Ana Galhoz, Gaurav Jain, Anna-Elisa Roser, Fabian Maass, Eleonora Carboni, Elisabeth Barski, Christof Lenz, Katja Lohmann, Christine Klein, Mathias Bähr, André Fischer, Michael P. Menden, Paul Lingor
    medRxiv 2021.06.08.21258527; doi: https://doi.org/10.1101/2021.06.08.21258527

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (216)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1096)
    • Dentistry and Oral Medicine (196)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
    • Epidemiology (9772)
    • Forensic Medicine (5)
    • Gastroenterology (481)
    • Genetic and Genomic Medicine (2313)
    • Geriatric Medicine (223)
    • Health Economics (462)
    • Health Informatics (1561)
    • Health Policy (736)
    • Health Systems and Quality Improvement (603)
    • Hematology (238)
    • HIV/AIDS (504)
    • Infectious Diseases (except HIV/AIDS) (11649)
    • Intensive Care and Critical Care Medicine (617)
    • Medical Education (238)
    • Medical Ethics (67)
    • Nephrology (257)
    • Neurology (2144)
    • Nursing (134)
    • Nutrition (337)
    • Obstetrics and Gynecology (427)
    • Occupational and Environmental Health (518)
    • Oncology (1180)
    • Ophthalmology (364)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (146)
    • Palliative Medicine (50)
    • Pathology (311)
    • Pediatrics (695)
    • Pharmacology and Therapeutics (300)
    • Primary Care Research (267)
    • Psychiatry and Clinical Psychology (2182)
    • Public and Global Health (4661)
    • Radiology and Imaging (778)
    • Rehabilitation Medicine and Physical Therapy (457)
    • Respiratory Medicine (624)
    • Rheumatology (274)
    • Sexual and Reproductive Health (226)
    • Sports Medicine (210)
    • Surgery (252)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)